Berenberg raised the firm’s price target on Sandoz (SDZNY) to CHF 41 from CHF 39 and keeps a Hold rating on the shares.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SDZNY:
- FDA adds boxed warning to Teva’s Copaxone for allergic reaction
- M&A News: Intra-Cellular Stock Rallies 36% on News of $14.6B Acquisition by Johnson & Johnson
- Intra-Cellular price target raised to $118 from $100 at BofA
- Venu Sports JV discontinued, Walgreens reports Q1 beat: Morning Buzz
- RBC buyers of Intra-Cellular after ‘more favorable-than-expected’ settlement